Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially identified in Wuhan …

Drug repurposing toward new medical uses and chiral switches are elements of secondary
pharmaceuticals. The drug repurposing and chiral-switches strategies have mostly been …

Drug repurposing has emerged as an important strategy and it has a great potential in
identifying therapeutic applications for COVID-19. An extensive virtual screening of 4193 …

The coronavirus disease 2019 (COVID‐19) is a severe worldwide pandemic. Due to the
emergence of various SARS‐CoV‐2 variants and the presence of only one Food and Drug …

SARS-CoV-2 is a positive single-strand RNA-based macromolecule that has caused the
death of more than 6.3 million people since June 2022. Moreover, by disturbing global …

Background: The lepromatous leprosy (LL) disease is caused by Mycobacterium leprae and
Mycobacterium lepromatosis which is characterized by inadequate response to treatment, a …

Introduction Although drug repurposing holds great potential in addressing unmet needs,
successful practical implementation is challenging and has been less widespread than …

Introduction Depression, the leading cause of disability worldwide, is known to be
exacerbated by severe acute respiratory syndrome coronavirus 2 infection, worsening …

This study introduces a dataset for drug-bacteria associations (DBA) that affects humans.
Our contribution extends beyond merely curating the association matrix; we also conduct …

Emergence of COVID-19 and thereafter intensive research on bioactive natural compounds
against SARS-CoV-2, identified a large number of phytochemicals (ie, plants-derived) and …